Encorafenib Impurity 15 | CAS 1229025-68-6 - Request Quote
Encorafenib Impurity 15
| SZ CAT No: | SZ-E056018 |
| CAS No | 1229025-68-6 |
| Mol.F. | C13H18N2O4 |
| Mol.Wt. | 266.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Encorafenib Impurity 15 is chemically Benzyl methyl propane-1,2-diyl(S)-dicarbamate. Encorafenib Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Encorafenib Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Encorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1229025-68-6
Purchase 1229025-68-6
Order 1229025-68-6
Enquire 1229025-68-6
price of 1229025-68-6
1229025-68-6 Supplier
1229025-68-6 Manufacturer
1229025-68-6 Exporter
buy high quality Encorafenib Impurity 15
Purchase Encorafenib Impurity 15
Encorafenib Impurity 15 suppliers
Encorafenib Impurity 15 manufacturers
Encorafenib Impurity 15 price
Order Encorafenib Impurity 15
Enquire Encorafenib Impurity 15
Encorafenib Impurity 15 cost
Encorafenib Impurity 15 Supplier
Encorafenib Impurity 15 Distributor
Encorafenib Impurity 15 for Method Validation
Encorafenib Reference Standard
Encorafenib Impurity 15 for ANDA Filing
Encorafenib Impurity 15 for Forced Degradation Studies
Encorafenib Impurity 15 Identification Standards
Encorafenib Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


